ENDURE Trademark

Trademark Overview

On Friday, June 17, 2016, a trademark application was filed for ENDURE with the United States Patent and Trademark Office. The USPTO has given the ENDURE trademark a serial number of 87075578. The federal status of this trademark filing is REGISTERED as of Tuesday, September 7, 2021. This trademark is owned by Sun Pharma Global FZE. The ENDURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical, scientific, and technological research services for others in the field of immunologically mediated inflammatory disorders and diseases
endure

General Information

Serial Number87075578
Word MarkENDURE
Filing DateFriday, June 17, 2016
Status700 - REGISTERED
Status DateTuesday, September 7, 2021
Registration Number6473653
Registration DateTuesday, September 7, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2021

Trademark Statements

Goods and ServicesMedical, scientific, and technological research services for others in the field of immunologically mediated inflammatory disorders and diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 23, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressVADODARA, GUJARAT 390012
IN
Party NameSun Pharma Global FZE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 7, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 22, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 2, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 20, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 11, 2020NON-FINAL ACTION E-MAILED
Wednesday, November 11, 2020NON-FINAL ACTION WRITTEN
Wednesday, November 11, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 20, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, October 6, 2020DATA MODIFICATION COMPLETED
Tuesday, October 6, 2020WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 30, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 1, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 1, 2020INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 1, 2020SUSPENSION INQUIRY WRITTEN
Monday, March 30, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, September 30, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 30, 2019LETTER OF SUSPENSION E-MAILED
Monday, September 30, 2019SUSPENSION LETTER WRITTEN
Monday, September 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 29, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, March 29, 2019INQUIRY TO SUSPENSION E-MAILED
Friday, March 29, 2019SUSPENSION INQUIRY WRITTEN
Thursday, March 28, 2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, September 27, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 27, 2018LETTER OF SUSPENSION E-MAILED
Thursday, September 27, 2018SUSPENSION LETTER WRITTEN
Wednesday, September 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 30, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, March 30, 2018INQUIRY TO SUSPENSION E-MAILED
Friday, March 30, 2018SUSPENSION INQUIRY WRITTEN
Monday, March 26, 2018SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, September 26, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 26, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, September 26, 2017SUSPENSION LETTER WRITTEN
Monday, September 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 21, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 23, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, March 23, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, March 23, 2017SUSPENSION INQUIRY WRITTEN
Thursday, March 23, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, March 23, 2017ASSIGNED TO LIE
Tuesday, September 20, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 20, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, September 20, 2016SUSPENSION LETTER WRITTEN
Monday, September 19, 2016ASSIGNED TO EXAMINER
Thursday, June 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 21, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

endure mediated immunologically inflammatory disorders diseases field others scientific technological research